GSK
3 years ago ⋅ English ⋅ 1 min read
Newsroom
GSK provides further update on phase III RSV maternal vaccine candidate programme

For media and investors onlyGlaxoSmithKline plc (LSE/NYSE: GSK) today announced that, further to the voluntary pause shared on February 18, the Company has decided to stop enrolment and... Read More
GSK
3 years ago ⋅ English ⋅ 4 min read
Newsroom
Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an adjuvanted plant-based COVID-19 vaccine

For media and investors only- A vaccine manufactured in plants and developed in CanadaMedicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today... Read More
GSK
3 years ago ⋅ English ⋅ 4 min read
Newsroom
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine

For media and investors only- Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralizing antibodies 18- to 30-fold across vaccine platforms (mRNA,... Read More
GSK
3 years ago ⋅ English ⋅ 3 min read
Newsroom
GSK announces independent Consumer Healthcare company is to be called Haleon

For media and investors only- Haleon will be a new world-leader in consumer health with an exceptional portfolio of category-leading brands, including Sensodyne, Voltaren, Panadol and C... Read More
GSK
3 years ago ⋅ English ⋅ 1 min read
Newsroom
GSK provides update on phase III RSV maternal vaccine candidate programme

For media and investors onlyGlaxoSmithKline plc (LSE/NYSE: GSK) today announced that it has voluntarily paused enrolment and vaccination in the GRACE phase III trial (NCT04605159), eval... Read More
GSK
3 years ago ⋅ English ⋅ 7 min read
Newsroom
China’s National Medical Products Administration approves Benlysta (belimumab) for adult patients with active lupus nephritis

For media and investors only- First and only biologic approved in China for both systemic lupus erythematosus and lupus nephritisGlaxoSmithKline plc (LSE/NYSE: GSK) today announced that... Read More